Document is current
Any future updates will be listed below
-
Authors
Zhao, Liwei
Liu, Peng
Sauvat, Allan
Carnet Le Provost, Killian
Liu, Jiani
Checcoli, Andrea
Pol, Jonathan https://orcid.org/0000-0002-8355-7562
Kepp, Oliver https://orcid.org/0000-0002-6081-9558
Kroemer, Guido https://orcid.org/0000-0002-9334-4405
Bezu, Lucillia https://orcid.org/0000-0002-3569-6066
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05742438 at ClinicalTrials.govnct04106999 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
nct03012971 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
nct06030804 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
nct03109990 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
nct03370588 at ClinicalTrials.govDocuments that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
Documents that mention this clinical trial
Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade
https://doi.org/10.1136/jitc-2024-010714
-
Funding
Funding for this research was provided by:
European Research Council (101052444)
European Research Council (ERC-2021-ADG)
Crimson (101016923)
the Philippe Foundation (N/A)
Institut Universitaire de France (N/A)
Fondation Carrefour (N/A)
Elior (N/A)
Fondation pour la Recherche Médicale (N/A)
Cancéropôle Ile de France (N/A)
Labex (ANR-18-IDEX-0001)
SIRIC CARPEM (N/A)
Seerave Foundation (N/A)
SIRIC SOCRATE (N/A)
Association pour la recherche sur le cancer (N/A)
the Monahan Foundation (N/A)
ImmunoLife (N/A)
Projects Oncobiome (N/A)
Prevalung (101095604)
Mark Foundation For Cancer Research (N/A)
ANR (21-ESRE-0028)
European Joint Programme on Rare Diseases (N/A)
Ligue Contre le Cancer (N/A)
Société Française d’Anesthésie et de Réanimation (N/A)
European Union Horizon 2020 (N/A)
Institut National Du Cancer (N/A)
- License Information
